Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
Total Valuation
Boston Scientific has a market cap or net worth of $113.11B. The enterprise value is $120.70B.
Market Cap$113.11B
Enterprise Value$120.70B
Share Statistics
Boston Scientific has 1,483,019,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,483,019,800
Owned by Insiders0.16%
Owned by Institutions6.48%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.13%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.13%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee315.98K
Profits Per Employee34.83K
Employee Count53,000
Asset Turnover0.43
Inventory Turnover2.31
Valuation Ratios
The current PE Ratio of Boston Scientific is 38.2. Boston Scientific’s PEG ratio is 4.27.
PE Ratio38.2
PS Ratio7.85
PB Ratio6.04
Price to Fair Value6.04
Price to FCF49.69
Price to Operating Cash Flow23.80
PEG Ratio4.27
Income Statement
In the last 12 months, Boston Scientific had revenue of 16.75B and earned 1.85B in profits. Earnings per share was 1.26.
Revenue16.75B
Gross Profit10.27B
Operating Income2.63B
Pretax Income2.28B
Net Income1.85B
EBITDA3.94B
Earnings Per Share (EPS)1.26
Cash Flow
In the last 12 months, operating cash flow was 4.63B and capital expenditures -851.00M, giving a free cash flow of 3.77B billion.
Operating Cash Flow4.63B
Free Cash Flow3.77B
Free Cash Flow per Share2.55
Dividends & Yields
Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-30.06%
50-Day Moving Average93.36
200-Day Moving Average100.10
Relative Strength Index (RSI)22.36
Average Volume (3m)14.92M
Important Dates
Boston Scientific upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).
Last Earnings DateFeb 4, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
Boston Scientific as a current ratio of 1.08, with Debt / Equity ratio of 51.49%
Current Ratio1.08
Quick Ratio0.64
Debt to Market Cap0.08
Net Debt to EBITDA2.73
Interest Coverage Ratio6.81
Taxes
In the past 12 months, Boston Scientific has paid 436.00M in taxes.
Income Tax436.00M
Effective Tax Rate0.19
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 36.10, with an EV/FCF ratio of 53.75.
EV to Sales8.49
EV to EBITDA36.10
EV to Free Cash Flow53.75
EV to Operating Cash Flow41.39
Balance Sheet
Boston Scientific has $1.27B in cash and marketable securities with $12.05B in debt, giving a net cash position of -$10.77B billion.
Cash & Marketable Securities$1.27B
Total Debt$12.05B
Net Cash-$10.77B
Net Cash Per Share-$7.26
Tangible Book Value Per Share-$1.20
Margins
Gross margin is 69.01%, with operating margin of 15.73%, and net profit margin of 11.07%.
Gross Margin69.01%
Operating Margin15.73%
Pretax Margin13.63%
Net Profit Margin11.07%
EBITDA Margin23.51%
EBIT Margin15.94%
Analyst Forecast
The average price target for Boston Scientific is $108.14, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$108.14
Price Target Upside45.90% Upside
Analyst ConsensusStrong Buy
Analyst Count22
Revenue Growth Forecast21.62%
EPS Growth Forecast54.80%